We also demonstrate that PKCβII promotes the endocytosis of TFR1 through the phosphorylation of AAK1, thereby facilitating ferroptosis and inhibiting tumor growth in vivo, which presents a potential therapeutic target for ferroptosis in clinical treatment. The gene discussed is TFRC; the disease is neoplasm.